| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 4.9× | −10.3× | |
| Price / Book | 111.0× | 1.0× | |
| Price / Sales | — | 83.1× | — |
| Price / Free cash flow | −120.2× | −10.2× | |
| EV / EBITDA | −119.3× | −20.9× | |
| Earnings yield | 20.5% | −9.7% | |
| Free cash flow yield | −0.8% | −3.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
BRNAS:BRVEBraveheart Bio Inc · 🇺🇸 NAS | $19.26 | +2.94% | $1.73B | −25.5× | −78.6% | — |
KRNAS:KRSAKorsana Biosciences Inc · 🇺🇸 NAS | $32.36 | −0.06% | $1.47B | −418.0× | −38.8% | +1266.2% |
CTNAS:CTYCITY THERAPEUTICS INC · 🇺🇸 NAS | $21.88 | −2.32% | $1.1B | −19.3× | 69.1% | — |
ATNAS:ATTOAttovia Therapeutics Inc · 🇺🇸 NAS | $14.13 | +2.91% | $645.05M | −10.3× | −40.4% | — |
BLNAS:BLSMBlossomHill Therapeutics Inc · 🇺🇸 NAS | $13.62 | −2.30% | $432.91M | −7.3× | 46.0% | — |
VONAS:VOGXVogenx Inc · 🇺🇸 NAS | $16.03 | +10.32% | $238.13M | −149.3× | 157.3% | — |
BSNAS:BSEMBioStem Technologies, Inc. · 🇺🇸 NAS | $1.50 | −28.23% | $26.77M | −5.7× | −16.8% | −56.7% |
CNNAS:CNSYCerenome, Inc. · 🇺🇸 NAS | $1.61 | −5.29% | $12.22M | −0.6× | −560.2% | +150.0% |
EONAS:EOCNEocene Ltd. · 🇺🇸 NAS | $2.81 | −1.41% | $2.93M | −0.3× | −65.3% | +95.2% |
